Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Henry

Showing results (1121-1130 of 1,163) with videos related to

Pageof 117
Sort By:
The American Journal of Tropical Medicine and Hygiene|February 10, 2026
Potent Monoclonal Antibodies Against Circulating Yellow Fever Virus Strains from Donors Immunized with the 17D VaccineMatheus O de Souza, Danielle R D Saunders, Andrew Miller, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Cellular stemness identifies high-risk ductal carcinoma <i>in situ</i> and offers a therapeutic interception opportunityE Schueddig, V Kochat, E Arslan, et al.
Nature Biotechnology|January 9, 2018
Functional interrogation and mining of natively paired human V<sub>H</sub>:V<sub>L</sub> antibody repertoiresBo Wang, Brandon J DeKosky, Morgan R Timm, et al.
The Lancet. Infectious Diseases|August 9, 2025
Dynamics of endemic virus re-emergence in children in the USA following the COVID-19 pandemic (2022-23): a prospective, multicentre, longitudinal, immunoepidemiological surveillance studyHai Nguyen-Tran, Sang Woo Park, Matthew R Vogt, et al.
Journal of Medicinal Chemistry|May 13, 2015
Discovery of 1-(3,3-dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl)phenyl)urea (LY3009120) as a pan-RAF inhibitor with minimal paradoxical activation and activity against BRAF or RAS mutant tumor cellsJames R Henry, Michael D Kaufman, Sheng-Bin Peng, et al.
Nature Microbiology|October 14, 2025
Cross-neutralizing and potent human monoclonal antibodies against historical and emerging H5Nx influenza virusesAlexandra A Abu-Shmais, Gray Freeman, Adrian Creanga, et al.
Nature Communications|January 4, 2024
Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerabilityJason Gorman, Crystal Sao-Fong Cheung, Zhijian Duan, et al.
Cell Reports|July 12, 2023
HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptideShuishu Wang, Flavio Matassoli, Baoshan Zhang, et al.
Ecology Letters|September 22, 2025
Borealisation of Plant Communities in the Arctic Is Driven by Boreal-Tundra SpeciesMariana García Criado, Isabel C Barrio, James D M Speed, et al.
Nature Communications|June 12, 2021
Experimental warming differentially affects vegetative and reproductive phenology of tundra plantsCourtney G Collins, Sarah C Elmendorf, Robert D Hollister, et al.
Pageof 117

Showing results (1121-1130 of 1,163) with videos related to

Sort By:
Pageof 117
The American Journal of Tropical Medicine and Hygiene|February 10, 2026
Potent Monoclonal Antibodies Against Circulating Yellow Fever Virus Strains from Donors Immunized with the 17D VaccineMatheus O de Souza, Danielle R D Saunders, Andrew Miller, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Cellular stemness identifies high-risk ductal carcinoma <i>in situ</i> and offers a therapeutic interception opportunityE Schueddig, V Kochat, E Arslan, et al.
Nature Biotechnology|January 9, 2018
Functional interrogation and mining of natively paired human V<sub>H</sub>:V<sub>L</sub> antibody repertoiresBo Wang, Brandon J DeKosky, Morgan R Timm, et al.
The Lancet. Infectious Diseases|August 9, 2025
Dynamics of endemic virus re-emergence in children in the USA following the COVID-19 pandemic (2022-23): a prospective, multicentre, longitudinal, immunoepidemiological surveillance studyHai Nguyen-Tran, Sang Woo Park, Matthew R Vogt, et al.
Journal of Medicinal Chemistry|May 13, 2015
Discovery of 1-(3,3-dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl)phenyl)urea (LY3009120) as a pan-RAF inhibitor with minimal paradoxical activation and activity against BRAF or RAS mutant tumor cellsJames R Henry, Michael D Kaufman, Sheng-Bin Peng, et al.
Nature Microbiology|October 14, 2025
Cross-neutralizing and potent human monoclonal antibodies against historical and emerging H5Nx influenza virusesAlexandra A Abu-Shmais, Gray Freeman, Adrian Creanga, et al.
Nature Communications|January 4, 2024
Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerabilityJason Gorman, Crystal Sao-Fong Cheung, Zhijian Duan, et al.
Cell Reports|July 12, 2023
HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptideShuishu Wang, Flavio Matassoli, Baoshan Zhang, et al.
Ecology Letters|September 22, 2025
Borealisation of Plant Communities in the Arctic Is Driven by Boreal-Tundra SpeciesMariana García Criado, Isabel C Barrio, James D M Speed, et al.
Nature Communications|June 12, 2021
Experimental warming differentially affects vegetative and reproductive phenology of tundra plantsCourtney G Collins, Sarah C Elmendorf, Robert D Hollister, et al.
Pageof 117